US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Unpacking a 17.61% Potential Upside in the Diagnostics & Research Sector

Investors looking for opportunities in the healthcare sector might find Waters Corporation (NYSE: WAT) an intriguing prospect, given its strategic positioning in the diagnostics and research..

ResMed Inc. (RMD) Investor Outlook: Unveiling a 28% Potential Upside in the Healthcare Sector

For investors keen on the healthcare sector, ResMed Inc. (NYSE: RMD) is a noteworthy contender, offering significant growth potential. With a market capitalization of $33.3 billion,..

AstraZeneca PLC (AZN) Stock Analysis: Eyeing Modest Upside Amid Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector and a prominent player among general drug manufacturers, continues to garner significant investor interest. With a..

Gilead Sciences, Inc. (GILD) Stock Analysis: A Healthcare Giant with a 15% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Foster City, California, Gilead..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 50% Potential Upside for Investors

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a Strong 3.12% Dividend Yield

As one of the leading global healthcare companies, Novartis AG (NYSE: NVS) stands out in the competitive landscape of drug manufacturing. Headquartered in Basel, Switzerland, Novartis..

Novo Nordisk A/S (NVO) Stock Analysis: Uncovering a 16% Upside Potential Amidst Robust Dividend Yields

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture investor attention with its compelling mix of strong financial metrics and strategic..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 11% Potential Upside in Healthcare

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, commanding a significant market presence with a capitalization of $294.66 billion. As..

AbbVie Inc. (ABBV) Stock Analysis: An In-Depth Look at Its 19.49% Upside Potential

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, has been a stellar performer in the drug manufacturing industry. With a market capitalization of $368.57..

Abivax SA (ABVX) Stock Analysis: Understanding the 26.72% Potential Upside in Biotech Innovation

Abivax SA (ABVX) is making waves in the biotechnology sector as a promising player headquartered in Paris, France. With a market cap of $9.97 billion, this..

Kamada Ltd. (KMDA) Stock Analysis: Assessing a 57.77% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israel-based leader in the specialty and generic drug manufacturing segment, is capturing investors’ attention with its promising upside potential. Currently trading..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) stands at an intriguing crossroads within the biotechnology sector. With a market capitalization of $492.3 million, this Boston-based company is..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93% Potential Upside Amidst Analyst Enthusiasm

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a burgeoning force in the biotechnology sector, is capturing investor attention with a staggering potential upside of 93%, as projected by..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a 61% Upside Potential in the Rare Disease Market

Eton Pharmaceuticals, Inc. (ETON), a specialized player in the healthcare sector focusing on treatments for rare diseases, is capturing the attention of investors with its substantial..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 39% Potential Upside

Investors with an eye on the healthcare sector may want to take a closer look at Emergent BioSolutions Inc. (NYSE: EBS), a company renowned for its..

COMPASS Pathways Plc (CMPS) Stock Analysis: Unveiling a 226% Potential Upside in Psychedelic Therapies

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents a compelling case with its substantial potential upside. As a pioneer in..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Growth in the Medical Care Facilities Sector

Enhabit, Inc. (NASDAQ: EHAB) stands as a noteworthy player in the healthcare sector, specializing in home health and hospice services across the United States. With a..

Cogent Biosciences, Inc. (COGT) Investor Outlook: 49.67% Potential Upside in Precision Therapy Innovation

Cogent Biosciences, Inc. (NASDAQ: COGT) is capturing investor attention with its innovative approach to precision therapies targeting genetically defined diseases. As a clinical-stage biotechnology company, Cogent..

Talkspace, Inc. (TALK) Stock Analysis: Exploring an 18.96% Upside in the Virtual Healthcare Arena

Investors seeking exposure to the burgeoning virtual healthcare landscape should take a closer look at Talkspace, Inc. (NASDAQ: TALK). Specializing in behavioral healthcare, Talkspace connects patients..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds